CytoPherx Obtains $34,000,000 New Funding Round

  • Feed Type
  • Date
    1/4/2012
  • Company Name
    CytoPherx
  • Mailing Address
    401 W. Morgan Rd. Ann Arbor, MI 48108
  • Company Description
    CytoPherx, Inc., founded in July 2007 and headquartered in Ann Arbor, Michigan, is a venture-backed, clinical stage medical device company addressing inflammation-based diseases and conditions with a proprietary selective cytopheresis system.
  • Website
    http://www.cytopherx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $34,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The funds will be used to complete U. S. clinical trials and gain FDA approval to commercialize the CytoPherx anti-inflammatory therapy for acute kidney injury.
  • M&A Terms
  • Venture Investor
    Early Stage Partners
  • Venture Investor
    ONSET Ventures
  • Venture Investor
    Capital Midwest Fund
  • Venture Investor
    Kaiser Permanente Ventures
  • Venture Investor
    Emergent Medical Partners
  • Venture Investor
    Aphelion Capital
  • Venture Investor
    Lurie Investments
  • Venture Investor
    Apjohn Ventures Fund

By posting a comment, you agree to our terms and conditions.